Currently Enrolling Studies
To learn more, call 319-356-4848 or e-mail recruit-vaccine-research@uiowa.edu.
Ongoing Studies (Closed to Enrollment)
Pfizer C4591081 Covid-19
Pfizer C4591081 Covid-19
A phase 3, randomized, double-blind, placebo-controlled clinical study evaluating safety, tolerability, immunogenicity and efficacy of a variant-adapted BNT162b2 vaccine in healthy participants 50 through 64 years of age.
Pfizer C3671013 RSV Substudy C
Pfizer C3671013 RSV Substudy C
A phase 3 study to evaluate the efficacy, immunogenicity, and safety of respiratory syncytial virus (RSV) prefusion f subunit vaccine in adults.
DMID 21-0009 Adult Influenza
DMID 21-0009 Adult Influenza
A phase 1, comparator-controlled, dosage-escalation study to evaluate the safety and immunogenicity of two doses DCVC H1 HA mRNA-LNP in healthy adults.
Complete this survey to see if you are eligible!